Nebenwirkungen · Capecitabine Medac
Capecitabine medac 150 mg film-coated tablets Capecitabine medac 500 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 16
HOS-218231 · Präparat HOS-216183
Table 5 Summary of related ADRs reported in patients treated with capecitabine in combination treatment in addition to those seen with capecitabine monotherapy or seen at a higher frequency grouping compared to capecitabine monotherapy Body system Very common Common Rare/Very rare (Post-marketing All grades All grades experience) Infections and - Herpes zoster, Urinary infestations tract infection, Oral candidiasis, Upper respiratory tract infection, Rhinitis, Influenza, + Infection, Oral herpes + Blood and Neutropenia, Bone marrow depression, + lymphatic system Leukopenia, +Anaemia, + Febrile neutropenia + disorders Neutropenic fever, Thrombocytopenia Immune system - Hypersensitivity disorders Metabolism and Appetite decreased Hypokalaemia, nutrition disorders Hyponatraemia, Hypomagnesaemia,
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-05-02T02:00:00Z · SHA-256 911762332dd30fd042dfa8a081c0eb1ec9e9d586a7284c79027e9cf3a76f4cf9 · Passage 630b682fac030b5531543744bc5779e14e18eb2ccb6507468375a85696ca5d18 · Zeichen 14462–16188 im Abschnitt